Skip to search formSkip to main contentSkip to account menu

A 64662

Known as: A-64662, Abbott 64662, Abbott-64662 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
We describe the development of a series of soluble, potent, and bioavailable nonpeptide renin inhibitors. These inhibitors… 
1990
1990
The effects of sustained renin inhibition by repeated administration of enalkiren (A- 64662), the novel dipeptide renin inhibitor… 
1990
1990
The effects of A-64662, a new specific renin inhibitor, on plasma renin activity (PRA) and blood pressure (BP) were studied for… 
Review
1990
Review
1990
Enalkiren (A-64662), a potent, dipeptide renin inhibitor, mimics the transition state of the human renin substrate… 
1989
1989
The potent and primate-selective renin inhibitor A-64662 (n = 8) or vehicle (n = 6) was administered intravenously for 7 days to… 
Highly Cited
1989
Highly Cited
1989
The effect of the renin inhibitor enalkiren (Abbott- 64662) was evaluated in eight normal volunteer subjects on a standardized… 
1989
1989
We studied the effects of intravenous injections of the renin inhibitor A-64662 on blood pressure, plasma renin activity (PRA… 
1988
1988
The efficacy of the potent, primate selective renin inhibitor A-64662 was studied in monkeys and rats with varying baseline…